marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q1
added 05-15-2023
Sorrento Therapeutics Financial Statements 2011-2025 | SRNE
Annual Financial Statements Sorrento Therapeutics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
590 M | 2.91 B | 516 M | 230 M | 520 M | 264 M | 194 M | 269 M | 152 M | 71.3 M | 54.6 M |
Shares |
295 M | 230 M | 133 M | 106 M | 69.7 M | 50.4 M | 36.9 M | 26.7 M | 15 M | 11.4 M | 9.92 M |
Historical Prices |
2.53 | 9.67 | 2.17 | 2.03 | 9.95 | 5.2 | 6.04 | 12.9 | 11.5 | 5 | 9.75 |
Net Income |
-428 M | -298 M | -292 M | -204 M | 9.13 M | -60.9 M | -45.8 M | -34.7 M | -21.9 M | -4.85 M | -3.24 M |
Revenue |
-126 K | 40 M | 31.4 M | 21.2 M | 152 M | 8.15 M | 4.59 M | 3.82 M | 460 K | 584 K | 529 K |
Cost of Revenue |
- | - | - | 7.06 M | 3.94 M | 811 K | 1.95 M | 2.04 M | 4.44 K | - | - |
Gross Profit |
- | 30 M | 19.2 M | 14.1 M | 148 M | 7.34 M | 2.64 M | 1.78 M | 456 K | - | 529 K |
Operating Income |
-401 M | -245 M | -259 M | -150 M | 25.3 M | -96.8 M | -74 M | -34.7 M | -21.7 M | -4.85 M | -3.24 M |
Interest Expense |
10.2 M | 20.2 M | 35 M | 57.6 M | 4.98 M | 1.61 M | 1.65 M | 1.63 M | 253 K | - | - |
EBITDA |
-389 M | -197 M | -191 M | -126 M | 54 M | -59.1 M | -48.8 M | -32.2 M | -14.9 M | -4.56 M | -3.08 M |
Operating Expenses |
- | 232 M | 214 M | 144 M | 96.5 M | 67.2 M | 52.6 M | 36.3 M | 16.1 M | 5.44 M | 3.77 M |
General and Administrative Expenses |
197 M | 116 M | 104 M | 63.6 M | 38.3 M | 24.2 M | 20.1 M | 9.99 M | 6.32 M | 1.61 M | 1.2 M |
All numbers in USD currency
Quarterly Income Statement Sorrento Therapeutics
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
543 M | 523 M | 452 M | 403 M | 337 M | 315 M | 299 M | 290 M | 281 M | 268 M | 251 M | 217 M | 183 M | 155 M | 131 M | 123 M | 122 M | 122 M | 117 M | 101 M | 84.9 M | 80.5 M | 76.9 M | 70.3 M | 50.9 M | 58.6 M | 66.2 M | 46.5 M | 38 M | 37.8 M | 37.3 K | 36.3 M | 36.2 M | 29.6 M | 28.5 M | 25.3 K | 23.1 K | 23 M | 14.1 M | 13.4 M | 12.3 M | 12 M | 12 M | 11.2 M | 261 M | 262 M | 262 M | 262 M | 262 M |
Net Income |
-140 M | - | -89.6 M | -219 M | -40.8 M | -144 M | -120 M | -167 M | 2.42 M | -71.5 M | -84 M | -77.7 M | -65.2 M | -62.8 M | -64.4 M | -56.8 M | -108 M | -49.8 M | -47.3 M | -73.9 M | -32.6 M | 48.4 M | -2.06 M | -14.2 M | -23.1 M | -17.9 M | 15.9 M | -43.3 M | -15.6 M | -26.6 M | -939 K | -11 M | -10.4 M | -8.5 M | -7.6 M | -8.45 M | -10.1 M | - | -3.36 M | -21.9 M | -21.9 M | - | -4.85 M | -4.85 M | -906 K | - | -702 K | -1.09 M | -684 K |
Revenue |
16.3 M | - | 62 K | 72 K | 18.4 M | 13.1 M | 164 K | -22 K | -419 K | 11.5 M | -566 K | -4.7 M | -556 K | 13 M | 5.78 M | 6.48 M | 6.14 M | 6.93 M | 4.1 M | 3.91 M | 6.25 M | 20.4 M | 122 M | 4.66 M | 4.87 M | 4.02 M | 2.24 M | 902 K | 988 K | 1.34 M | 1.1 M | 1.17 M | 977 K | 798 K | 1.28 M | 775 K | 976 K | - | 83 K | 142 K | 134 K | - | 135 K | 217 K | 110 K | - | 91.8 K | 74.2 K | 235 K |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.28 M | 2.31 M | - | 2.18 M | 1.23 M | 1.31 M | - | 1.08 M | 816 K | 1.06 M | - | 418 K | 295 K | 359 K | - | 604 K | 314 K | 509 K | - | 527 K | 510 K | 563 K | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-106 M | - | -109 M | -118 M | -107 M | - | -101 M | -101 M | -84.9 M | - | -83.1 M | -47.7 M | -43.2 M | - | -53.3 M | -50.4 M | -123 M | - | -47.9 M | -28.4 M | -32.5 M | - | 96.9 M | -13.5 M | -23.3 M | - | -12.2 M | -44.7 M | -22 M | - | -35.6 M | -10.5 M | -10.2 M | - | -7.13 M | -7.99 M | -9.87 M | - | -3.31 M | -4.72 M | -2.51 M | - | -1.24 M | -945 K | -908 K | - | -704 K | -1.09 M | -686 K |
Interest Expense |
1.13 M | - | 792 K | 2.31 M | 3.25 M | - | 2.9 M | 2.02 M | 2.37 M | - | 2.56 M | 8.3 M | 6.81 M | - | 9.46 M | 9.52 M | 9.08 M | - | 2.68 M | 45 M | 1.05 M | - | 1.21 M | 1.2 M | 1.61 M | - | 236 K | 273 K | 307 K | - | 396 K | 442 K | 439 K | - | 476 K | 468 K | 223 K | - | 51 K | 22 K | 10 K | - | - | - | - | - | - | - | - |
EBITDA |
-103 M | - | -99.6 M | -112 M | -104 M | - | -91.8 M | -94.5 M | -82 M | - | -74.3 M | -42.1 M | -40.1 M | - | -45 M | -44.4 M | -120 M | - | -41.7 M | -24.4 M | -30.5 M | - | 102 M | -10.3 M | -21.9 M | - | -11 M | -43.6 M | -21.5 M | - | -33.8 M | -9.11 M | -9.35 M | - | -4.76 M | -6.42 M | -9.1 M | - | -2.67 M | -4.39 M | -2.41 M | - | -1.03 M | -813 K | -845 K | - | -600 K | -1.03 M | -673 K |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.39 M | 4.86 M | 2.65 M | - | 1.38 M | 1.16 M | 1.02 M | - | 795 K | 1.16 M | 921 K |
General and Administrative Expenses |
55 M | - | 50.2 M | 48.1 M | 44.3 M | - | 48.5 M | 50.3 M | 43.4 M | - | 24.3 M | 24.5 M | 26.3 M | - | 25.2 M | 27.8 M | 25.1 M | - | 20.1 M | 11 M | 9.96 M | - | 10.2 M | 9.09 M | 11.9 M | - | 5.27 M | 4.22 M | 4.5 M | - | 4.71 M | 3.07 M | 2.22 M | - | 1.85 M | 2.36 M | 3.38 M | - | 1.11 M | 1.51 M | 1.25 M | - | 427 K | 245 K | 219 K | - | 159 K | 527 K | 333 K |
All numbers in USD currency